https://www.selleckchem.com/pr....oducts/2-3-cgamp.htm
43; 95% CI .062 - 3.32; p=.3989). Among CD patients treated anti-TNF-α medications an increase in the incidence of MS, compared to CD patients not exposed to such medications was observed (IRR=2.62; 95% CI 1.00 to 6.83; p=0.049), statistically significant. After adjusting for age/gender, patients with CD using anti-TNF-α agents had an increase of incidence in MS (adjusted IRR 2.24; 95% CI 0.85 - 5.94; p=.1035) but it was not statistically significant. Use of anti-TNF-α drugs in CD was associated with a statistically significant increa
Like
Comment
Share
